Italia markets close in 8 hours 6 minutes

Medigene AG (0QGJ.L)

LSE - LSE Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
2,1500-0,1300 (-5,70%)
Al 08:02AM GMT. Mercato aperto.
Schermo intero
Chiusura precedente2,2800
Aperto0,0000
Denaro0,0000 x N/D
Lettera0,0000 x N/D
Min-Max giorno0,0000 - 0,0000
Intervallo di 52 settimane
Volume2.320
Media VolumeN/D
Capitalizzazione527.977
Beta (5 anni mensile)0,89
Rapporto PE (ttm)N/D
EPS (ttm)-0,4060
Prossima data utiliN/D
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Medigene Receives $3 Million Milestone Payment from 2seventy bio

    Milestone payment is related to the establishment of 2seventy bio’s strategic partnership with JW TherapeuticsPayment provides further validation of Medigene’s end-to-end platform MARTINSRIED, Germany and MUNICH, Germany, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Martinsried -- Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology company focused on the development of differentiated, best-in-class T Cell Receptor engineered T cell (TCR-T) therapies, today announced that it has received a

  • GlobeNewswire

    Medigene Announces Strategy and Corporate Update

    Company strategy focused on developing differentiated TCR-T therapies from its proprietary “end-to-end” platform to target solid tumors with high unmet needPipeline expansion and acceleration of lead candidates with aim of advancing them into clinical developmentLead program, MDG1015, a TCR-T therapy for NY-ESO-1 combined with PD1-41BB Switch Receptor technology; at CTA /IND enabling phase, with submission planned for 2H 2024Second program, MDG10xx, TCR-T therapies for yet undisclosed targets co